Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rosai-Dorfman Disease”

11 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 11 of 11 results

Not applicableLooking for participantsNCT03329274
What this trial is testing

Registry for Patients With Erdheim-Chester Disease and Other Histiocytoses

Who this might be right for
Erdheim-Chester Disease
Memorial Sloan Kettering Cancer Center 500
Post-approval studies (Phase 4)UnknownNCT05284942
What this trial is testing

Central China Rosai-Dorfman Disease Registry

Who this might be right for
Rosai-Dorfman DiseaseLangerhans Cell Histiocytosis
Tongji Hospital 20
Not applicableActive Not RecruitingNCT03127709
What this trial is testing

Memory, Thinking, and Brain Imaging in Adults With Histiocytosis

Who this might be right for
Histiocytosis
Memorial Sloan Kettering Cancer Center 13
Testing effectiveness (Phase 2)UnknownNCT04924647
What this trial is testing

Lenalidomide and Dexamethasone for Rosai-Dorfman Disease

Who this might be right for
Rosai-Dorfman Disease
Peking Union Medical College Hospital 16
Very early researchLooking for participantsNCT05093335
What this trial is testing

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Who this might be right for
Non-Hodgkin LymphomaMultiple MyelomaHistiocytic Neoplasms+2 more
Memorial Sloan Kettering Cancer Center 30
Testing effectiveness (Phase 2)Looking for participantsNCT07187167
What this trial is testing

Efficacy and Safety of the RD Regimen(Lenalidomide, Dexamethasone) for Rosai-Dorfman Disease

Who this might be right for
Rosai-Dorfman Disease
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 40
Testing effectiveness (Phase 2)Looking for participantsNCT06153173
What this trial is testing

Mirdametinib in Histiocytic Disorders

Who this might be right for
Langerhans Cell Histiocytosis (LCH)Juvenile Xanthogranuloma (JXG)Rosai-Dorfman Disease (RDD)+1 more
Children's Hospital Medical Center, Cincinnati 40
Testing effectiveness (Phase 2)Looking for participantsNCT04079179
What this trial is testing

Cobimetinib in Refractory Langerhans Cell Histiocytosis (LCH), and Other Histiocytic Disorders

Who this might be right for
Langerhan's Cell HistiocytosisJuvenile XanthogranulomaErdheim-Chester Disease+4 more
Carl Allen 90
Not applicableLooking for participantsNCT02285582
What this trial is testing

International Rare Histiocytic Disorders Registry (IRHDR)

Who this might be right for
Rare Histiocytic Disorders (RHDs)Erdheim-Chester Disease (ECD)Rosai-Dorfman Disease (RDD)+7 more
The Hospital for Sick Children 400
Early research (Phase 1)Looking for participantsNCT06712810
What this trial is testing

Q702 for the Treatment of Patients With Hematologic Malignancies

Who this might be right for
Hematopoietic and Lymphatic System NeoplasmHistiocytic SarcomaMalignant Histiocytosis+34 more
Mayo Clinic 46
Not applicableLooking for participantsNCT05915208
What this trial is testing

Histiocytic Disorder Follow-up Study

Who this might be right for
HistiocytosisLangerhans Cell HistiocytosisErdheim-Chester Disease+3 more
University of Alabama at Birmingham 6,000